Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Aug 21;15(8):e0234733. doi: 10.1371/journal.pone.0234733

Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

Fang Duan 1,#, Yan Zheng 2,#, Qian Zhao 2, Ze Huang 2, Yuedan Wu 2, Guoyi Zhou 2,*, Xiang Chen 1,*
Editor: Wen-Jun Tu3
PMCID: PMC7444505  PMID: 32822350

Abstract

Purpose

To investigate the knowledge and practices regarding diabetic retinopathy (DR) among diabetic patients included in a community-based primary health system (CBPHS) in China.

Methods

Diabetic patients aged 18 years and above registered in the CBPHS in Yueqing city, Zhejiang province were recruited. Information obtained by questionnaire included: demographic and socioeconomic status, knowledge about DR, and ocular and medical history. The primary outcome was whether the participant knew that DM can affect the eyes, defined according to the question: “Do you know diabetes mellitus (DM) can affect eyes? (yes or no)”. A knowledge score was calculated based on the responses to seven questions, with 1 point awarded for a correct response and 0 points for an incorrect or uncertain answer.

Results

A total of 1972 diabetic patients were included in the study with an average age of 65.2±10.8 years, 45.7% were male. One thousand two hundred and nineteen patients (61.8%) knew that DM can affect the eyes. Significant differences in age, education, income status, insurance covering eye care, fasting blood glucose, duration of DM, history of hypertension existed between subjects who knew and those who did not know that DM can affect the eyes (P<0.05 for all). The proportion of correct answers to the DR knowledge questions ranged from 33.3% to 61.8%, with an average score of 3.65±2.47. In the multiple regression analysis, the knowledge score was significantly associated with age, education, income, history of hypertension, duration of DM, being told that regular examinations should be performed and concern about vision loss (P <0.01 for all).

Conclusions

The knowledge toward DR among DM patients were still low within the chronic disease management system in eastern China. Routine ophthalmic screening, health care promotions, and educational programs should be emphasized and implemented for better DR prevention and management.

Introduction

Diabetes mellitus (DM) is a major public health problem worldwide, and its prevalence is increasing at an alarming rate with population growth and aging [1]. As reported by the International Diabetes Federation (IDF), there were 451 million diabetic patients worldwide in 2017, which is expected to increase to 693 million by 2045 [2]. It was reported that the prevalence of DM in China reached 10.9% in 2013, which was nearly 10-fold of that in the 1980s, and that for prediabetes was 35.7% [3]. Diabetic retinopathy (DR) is a leading cause of vision loss worldwide and a common ocular complication of DM, occurring in one of three diabetic patients [47]. However, previous studies have found that nearly half of the DR patients in China have never received any ocular examination [8].

Early detection and intervention of DR had been showed to be critical to prevent irreversible blindness and improve the patient’s quality of life [9]. And the efficacy and cost effectiveness of early detection and treatment of DR had been well established [10]. Previous studies found that a lack of DR knowledge was associated with poor patients adherence [8, 11]. In our previous study, we used an in-depth interview method to explore the influencing factors on the compliance of timely visits among patients with proliferative diabetic retinopathy, and found that more than 90% of the patients were lacking knowledge about DR [12]. A recent Cochrane review showed that interventions to increase awareness about DR are vital in improving attendance for DR screening, and thus a potentially important solution for reducing blindness caused by DR [13]. Therefore, patient awareness and knowledge about DR will be the key to successful disease management and prevention.

In order to support patients with chronic diseases, a community-based primary health system (CBPHS) was introduced throughout the entire nation to enable access to basic and less costly healthcare services, especially after the New Health Reform in 2009, which called for medical insurance coverage for more than 90% of Chinese people [14]. Hospital-based model has been shifted to delivery in primary settings. The CBPHS has proven to be very helpful to manage chronic diseases [15]. Free regular blood glucose tests are provided for diabetes patients registered in the CBPHS, but DM complications are not necessarily assessed. Since the previous studies on the patient awareness and knowledge of DR were based on general population, and the CBPHS has been carried out for several years in China, it is necessary to evaluate the potential changes CBSPHS may bring in the DM patients. Therefore, the present study aimed to evaluate the awareness and knowledge about DR, as well as the associated risk factors, among DM populations registered in the CBPHS in China. The information will be very useful to better inform future policy-making regarding DR prevention and treatment.

Methods

Yueqing City is located in the east of Zhejiang Province, China, covering an area of 1286.90 square kilometers with a population of over 1 million. Yuecheng community and Nanyue community were selected to represent the urban and suburban areas of Yueqing City, respectively. Patients aged 18 years and above with a history of physician-diagnosed DM who were registered in the CBPHS were invited to participate in this study. In detail, there were 3156 DM patients in Yuecheng community and 1300 participants were selected by simple random sampling method. There were 923 DM patients in Nanyue community and all of them were invited to participate. The exclusion criteria included a DM history of less than 12 months and inability to cooperate with the interviewer. Questionnaires were administered by a trained community physician. The study was conducted between May and September 2017. Ethical approval was obtained from the Yueqing Hospital Ethical Review Board, and the study adhered to the Declaration of Helsinki. Written informed consent was received from all participants.

The study questionnaire was modified according to a previous study [8], consisting of three parts. The first part included questions assessing the patient’s demographic and socioeconomic status, including age, gender, contact information, education level, monthly income, and information of medical insurance. The second part assessed the patient’s medical history of DM, including the type, duration, diagnosis, and history of DM-related diseases. The third part assessed the patient’s knowledge and actual practice regarding DR, including a knowledge section (7 questions about DR knowledge, e.g., Does DM affect eyes? How to know DM has affected your eyes?).

The primary outcome of the study was whether the participant knew that DM can affect the eyes, defined according to the question “Do you know diabetes mellitus can affect eyes? (yes or no)”. Categorical and continuous outcomes were compared using Chi-squared tests and t tests, respectively. To assess the participants’ knowledge about DR, a knowledge score was calculated based on the responses to 7 questions in the knowledge section, with 1 point awarded for a correct response and 0 points for an incorrect or uncertain answer. All variables significant at the 0.05 level in univariate analysis then were entered into multiple regression. Multiple linear regression was performed to estimate the association between the knowledge score and other factors, such as the demographic and socioeconomic status and DM history. A P value <0.05 was considered to be statistically significant. All statistical analyses were performed using Stata 12.0 (StataCorp, College Station, TX, USA).

Results

A total of 1972 diabetic patients completed the questionnaires in the two communities, 1151 from Yuecheng community and 821 from Nanyue community. The mean (standard deviation) age was 65.2±10.8 years, and 45.7% were male. Among all study participants, 1219 patients (61.8%) knew that DM can affect the eyes. As shown in Table 1, subjects who knew that DM can affect the eyes were significantly younger than those who did not know (P<0.001). There were significant differences in education, income status and the insurance covering eye care between subjects who knew and those who did not know that DM can affect the eyes (P<0.001, P = 0.028 and P<0.001, respectively). No significant difference existed regarding the insurance covering DM between patients in these two groups.

Table 1. Demographic and socioeconomic status of study participants.

Factors All (n = 1972) Did not know DM affects eyes (n = 753) Knew DM affects eyes (n = 1219) P*
Age (years), mean (SD) 65.2 (10.8) 66.8 (10.7) 64.1 (10.7) <0.001
Males, n (%) 902 (45.7) 309 (41.1) 593 (48.7) 0.001
Education, n (%) <0.001§
 None 541 (27.4) 259 (34.4) 282 (23.1)
 Elementary school 641 (32.5) 241 (32.0) 400 (32.8)
 Junior high school 447 (22.7) 150 (19.9) 297 (24.4)
 High school 273 (13.8) 75 (9.96) 198 (16.2)
 College or above 70 (3.55) 28 (3.72) 42 (3.45)
Monthly family income (USD), n (%) 0.028§
 1–300 227 (11.5) 112 (14.9) 115 (9.43)
 301–450 327 (16.6) 124 (16.5) 203 (16.7)
 451–750 475 (24.1) 156 (20.7) 319 (26.2)
 751–1500 648 (32.9) 269 (35.7) 379 (31.1)
 >1500 295 (15.0) 92 (12.2) 203 (16.7)
Insurance covering DM, n (%) 0.860
 Self-pay 87 (4.41) 34 (4.52) 53 (4.35)
 Social health insurance 1,885 (95.6) 719 (95.5) 1,166 (95.7)
Insurance covering eye care, n (%) <0.001
 Yes 423 (21.5) 156 (20.7) 267 (21.9)
 No 623 (31.6) 204 (27.1) 419 (34.4)
 Not sure 926 (47.0) 393 (52.2) 533 (43.7)

SD: standard deviation, 1 USD = 6.67 RMB, DM: diabetes mellitus

* P values were for comparing participant characteristics between the two groups.

t test was used.

Chi-squared test was used.

§ Ordinal logistic regression was used.

As shown in Table 2, most patients in both groups had type 2 DM (96.9%). Subjects who knew that DM can affect the eyes had a higher fasting blood glucose and longer duration of diabetes compared to those who did not know (both P < 0.001). Approximately half of the subjects knew that they had DM through their physical check-up, 48.8% through presenting discomfort in the body and less than 1% through presenting discomfort in the eyes. Subjects who did not know that DM can affect the eyes had a lower proportion of using insulin and more concerns with using insulin (P<0.001 and P = 0.002, respectively). In addition, more subjects who knew that DM can affect the eyes had a history of hypertension (P = 0.012), while the history of hypercholesterolemia was similar between the two groups.

Table 2. Medical history of diabetes among study participants by their knowledge of diabetes.

All (n = 1972) Did not know DM affect eyes (n = 753) Knew DM affect eyes (n = 1219) P*
DM type, n (%) 0.051
 Type 1 61 (3.1) 16 (2.1) 45 (3.7)
 Type 2 1,911 (96.9) 737 (97.9) 1174 (96.3)
Fasting blood glucose (mmol/L) Mean (SD) 7.00 (1.45) 6.86 (1.28) 7.08 (1.54) 0.001
Years since DM diagnosed 6.24 (4.38) 5.52 (3.96) 6.69 (4.57) <0.001
How to know you have DM, n (%) <0.001§
 Physical check-up 999 (50.7) 423 (56.2) 576 (47.3)
 Discomfort in the body 963 (48.8) 326 (43.3) 637 (52.3)
 Discomfort in the eyes 10 (0.51) 4 (0.53) 6 (0.49)
Using insulin, n (%) 184 (9.33) 46 (6.11) 138 (11.3) <0.001
Concerns with using insulin, n (%) 0.002
 None 146 (7.56) 70 (9.50) 76 (6.37)
 Barely 525 (27.2) 167 (22.7) 358 (30.0)
 Some 848 (43.9) 303 (41.1) 545 (45.7)
 Substantial 411 (21.3) 197 (26.7) 214 (17.9)
History of hypertension, n (%) 1,175 (59.6) 422 (56.0) 753 (61.8) 0.012
History of hypercholesterolemia, n (%) 0.134
 No 1,335 (67.7) 519 (68.9) 816 (66.9)
 Yes 244 (12.4) 79 (10.5) 165 (13.5)
 Not sure 393 (19.9) 155 (20.6) 238 (19.5)

SD: standard deviation

* P values were for comparing the participants’ medical history between the two groups.

Chi-squared test was used.

t test was used.

§ Fisher’s exact test was used.

Ordinal logistic regression was used.

The prevalence of diagnosed DR was significantly higher among subjects who knew that DM can affect the eyes (P<0.001) (Table 3). Most subjects who knew that DM can affect the eyes obtained instructions for regular eye examinations from physicians (57.8%). There were 1587 patients (80.9%) who had never undergone an eye examination, and only 178 patients (9.07%) underwent a yearly eye examination. The frequency of eye examinations was significantly different between the two groups (P<0.001). The main obstacle to having an eye examination was “vision is not affected” for all subjects, accounting for 41.1%. A lack of company was another important barrier to having an eye examination for the study participants in both groups. Regarding how the subjects knew that DM had affected their eye, subjects who knew through a fundus examination after pupil dilation only accounted for 5.98%; most subjects knew through discomfort in their eyes (43.1%). Only 29.5% of subjects thought that DM patients should have their eyes examined annually, and this percentage was significantly higher among subjects who knew that DM can affect the eyes. Additionally, 8.77% of subjects thought there was no need to have their eyes checked because of diabetes, and this percentage was significantly higher among subjects who did not know that DM can affect the eyes. Furthermore, people who did not know that DM can affect the eyes tended to be less anxious toward losing vision (P<0.001).

Table 3. History of ophthalmic care among diabetic patients by their knowledge of diabetes.

All (n = 1972) Did not know DM affects eyes (n = 753) Knew DM affects eyes (n = 1219) P*
Diagnosed with DR, n (%) 95 (4.82) 14 (1.86) 81 (6.64) <0.001
Told regular eye examination should be done, n (%) <0.001
 Never 613 (31.1) 434 (57.6) 179 (14.7)
 Yes, only by physician 966 (49.0) 261 (34.7) 705 (57.8)
 Yes, only by ophthalmologist 95 (4.82) 9 (1.20) 86 (7.05)
 Yes, by physician and ophthalmologist 298 (15.1) 49 (6.51) 249 (20.4)
Frequency of eye examinations, n (%) <0.001
 Never 1,587 (80.9) 673 (90.2) 914 (75.2)
 More than 5 years 56 (2.85) 18 (2.41) 38 (3.13)
 Every 3 to 5 years 61 (3.11) 12 (1.61) 49 (4.03)
 Every 2 years 57 (2.91) 13 (1.74) 44 (3.62)
 Yearly 178 (9.07) 28 (3.75) 150 (12.3)
 More often than yearly 23 (1.17) 2 (0.27) 21 (1.73)
Told the time of next follow-up visit, among participants who ever had eye examination, n (%) 246 (63.9) 29 (36.3) 217 (71.2) <0.001
Obstacle to having an eye examination, n (%) <0.001§
 No time 380 (19.3) 110 (14.6) 270 (22.2)
 No company 603 (30.6) 209 (27.8) 394 (32.3)
 Poor transportation 96 (4.87) 32 (4.25) 64 (5.25)
 Unreliable doctor 40 (2.03) 23 (3.05) 17 (1.39)
 No money 42 (2.13) 6 (0.80) 36 (2.95)
 Vision is not affected 811 (41.1) 373 (49.5) 438 (35.9)
How to know DM had affected eyes, n (%) <0.001
 Vision test 450 (22.8) 177 (23.5) 273 (22.4)
 Vision and ocular surface 139 (7.05) 43 (5.71) 96 (7.88)
 Discomfort in the eye, such as pain and blurry vision 850 (43.1) 280 (37.2) 570 (46.8)
 Fundus examination after pupil dilation 118 (5.98) 8 (1.06) 110 (9.02)
 Not sure 415 (21.0) 245 (32.5) 170 (14.0)
How often should diabetics have their eyes examined, n (%) <0.001
 Yearly 581 (29.5) 141 (18.7) 440 (36.1)
 Every 2 years 318 (16.1) 84 (11.2) 234 (19.2)
 3–5 years 91 (4.61) 36 (4.78) 55 (4.51)
 More than every 5 years 96 (4.87) 24 (3.19) 72 (5.91)
 Never 173 (8.77) 110 (14.6) 63 (5.17)
 Not sure 713 (36.2) 358 (47.5) 355 (29.1)
Concern about vision loss, n (%) <0.001§
 Never 433 (22.0) 328 (43.6) 105 (8.61)
 Rarely 803 (40.7) 284 (37.7) 519 (42.6)
 Sometimes 562 (28.5) 117 (15.5) 445 (36.5)
 Often 130 (6.59) 19 (2.52) 111 (9.11)
 Very often 44 (2.23) 5 (0.66) 39 (3.20)

* P values were for comparing the history of ophthalmic care between the two groups.

Chi-squared test was used.

Ordinal logistic regression was used.

§ Fisher’s exact test was used.

The subjects’ knowledge about DR are shown in Table 4; the proportion of correct answers to the other 6 questions regarding DR knowledge (besides DM can affect the eyes) ranged from 33.3% to 61.0%, with an average score of 3.65±2.47. The association between the knowledge score and other risk factors is shown in Table 5. In the multiple regression analysis, the knowledge score was significantly associated with age, education, income, history of hypertension, duration of DM, being told that regular examinations should be performed and concern about vision loss. In detail, age was negatively associated with knowledge score (β = -0.02, 95% CI: -0.03, -0.01, P<0.001). The higher level of education was associated with higher score of knowledge: elementary school vs. none, β = 0.54, 95% CI: 0.30, 0.78, P<0.001; junior high school vs. none, β = 0.97, 95% CI: 0.69, 1.24, P<0.001; high school vs. none, β = 0.96, 95% CI: 0.64, 1.29, P<0.001; college or above vs. none, β = 1.28, 95% CI: 0.76, 1.79, P<0.001. Higher level of family income was associated with higher score: 301–450 USD vs. < = 300USD, β = 0.55, 95%CI: 0.21, 0.89, P = 0.001; 451–750 USD vs. < = 300USD, β = 0.46, 95%CI: 0.14, 0.78, P = 0.005. History of hypertension and years since DM diagnosed were positive associated knowledge score (β = 0.27, 95% CI: 0.09, 0.46, P = 0.003 and β = 0.04, 95% CI: 0.02, -0.06, P<0.001 respectively). Told regular eye examination should be done and concern about vision loss were positive associated knowledge score (β = 2.07, 95% CI: 1.87, 2.28, P<0.001 and β = 1.60, 95% CI: 1.37, 1.83, P<0.001 respectively).

Table 4. Knowledge about diabetic retinopathy among diabetic patients (n = 1972).

Correct Correct proportion (%)
Knowledge questions, n (%)
 DM can affect eyes 1219 61.8
 DM can cause blindness 999 50.7
 DR is preventable 1145 58.1
 DR is treatable 1202 61.0
 Diabetic patients are more likely to get eye disease 1105 56.0
 DR usually has early symptoms 659 33.4
 Regular eye examinations are necessary 866 43.9

Table 5. Linear regression model for risk factors of participant’s knowledge score about diabetic eye diseases (n = 1972).

Simple linear regression Multiple linear regression
Beta coefficient (95% CI) P Beta coefficient (95% CI) P
Age (years) -0.03 (-0.04, 0.02) <0.001 -0.02 (-0.03, -0.01) <0.001
Males 0.32 (0.11, 0.54) 0.004 -0.001 (-0.19, 0.19) 0.991
Education
 None Reference Reference
 Elementary school 0.51 (0.23, 0.79) <0.001 0.54 (0.30, 0.78) <0.001
 Junior high school 0.90 (0.59, 1.20) <0.001 0.97 (0.69, 1.24) <0.001
 High school 1.08 (0.72, 1.43) <0.001 0.96 (0.64, 1.29) <0.001
College or above 1.18 (0.58, 1.79) <0.001 1.28 (0.76, 1.79) <0.001
Monthly family income (USD)
 1–300 Reference Reference
 301–450 0.77 (0.35, 1.18) <0.001 0.55 (0.21, 0.89) 0.001
 451–750 0.87 (0.48, 1.25) <0.001 0.46 (0.14, 0.78) 0.005
 751–1500 0.44 (0.07, 0.81) 0.021 0.08 (-0.25, 0.40) 0.649
 >1500 1.10 (0.68, 1.52) <0.001 0.25 (-0.11, 0.61) 0.168
Yuecheng community (Nanyue community as reference) 0.19 (-0.03, 0.41) 0.090
Type 2 DM (type 1 as reference) -0.55 (-1.18, 0.08) 0.087
Fasting blood glucose (mmol/L) 0.05 (-0.03, 0.12) 0.227
Using insulin (yes/no) 0.94 (0.57, 1.31) <0.001 0.28 (-0.03, 0.58) 0.078
History of hypertension (yes/no) 0.25 (0.02, 0.47) 0.030 0.27 (0.09, 0.46) 0.003
Years since DM diagnosed 0.07 (0.04, 0.09) <0.001 0.04 (0.02, 0.06) <0.001
Diagnosed as DR (yes/no) 1.08 (0.57, 1.58) <0.001 0.31 (-0.11, 0.73) 0.149
Used to have eye examinations (yes/no) 0.96 (0.69, 1.23) <0.001 0.14 (-0.10, 0.38) 0.244
Told regular eye examinations should be done (never vs combined other options, never as reference) 2.75 (2.55, 2.95) <0.001 2.07 (1.87, 2.28) <0.001
Concern about vision loss (never vs combined other options, never as reference) 2.56 (2.32, 2.80) <0.001 1.60 (1.37, 1.83) <0.001

1 USD = 6.67 RMB, DM: diabetes mellitus, DR: diabetic retinopathy

All variables with P<0.05 in the simple regression analysis were included in the multiple regression analysis.

Discussion

In this study, we investigated the knowledge and practices regarding DR among adult DM patients registered in the CBPHS in eastern China via questionnaires, and found approximately 50% of the participants knew the knowledge about DR. Knowledge about DR was related to age, education, family income, hypertension, diabetic duration, concern about vision loss and being told that regular eye examinations should be performed. Our results showed that despite the local residents were given free regular blood glucose tests and other types of DM management through the existing chronic disease management system, but more than one third of patient still knew little of DR and its prevention. This finding reveals how to improve knowledge of DR within the chronic disease management system is the key to battle with this preventable blindness-causing disease.

In the current study, all the study participants were recruited from the local CBPHS system. We found that only 61.8% of the participants knew that DM can affect the eyes, and only 50.7% knew that DM can cause blindness. The proportion of correct answers to the other questions ranged from 33.4% to 61%, indicating a poor to intermediate overall level of knowledge regarding DR among DM patients. This finding is similar to another population-based study in a suburban area (40.7%) [16], but lower than that reported in Shanghai (82.3%) [17]. However, there was no available previous data could be used to directly compare with CBPHS; therefore, our findings only provide some preliminary findings of the impact of CBPHS on DR knowledge. There are large variabilities in the reported knowledge level about DR in the literature: 37% in Australia, 65% in the USA and 27% in India [1820]. A hospital-based study in Zhejiang and a community-based study in Liaoning, China reported that 67% and 68% of the study subjects, respectively, were unaware that diabetes can affect the eyes [21, 22]. The differences among these studies could be partly explained by differences in health care systems, study populations and methods. Despite numerous health education programs on diabetes having been implemented, the IDF report shows the most DM patients still lack sufficient knowledge about the complications associated with diabetes [23]. Studies have reported that the most common complication known by DM patients is heart disease, followed by cerebrovascular and renal disease, while fewer people are aware that DM can also affect the eyes [24]. In our study, people who had been diagnosed with DR were more likely to know that DM can affect the eyes than those who had not. However, given 80.9% patients never underwent an eye examination in our study, the diagnosed rate of DR (4.82%) may be far less than the real DR prevalence. One study in urban China found that more than 90% of subjects with DR were unaware that they had been affected by this eye condition [25], and the Beijing Eye Study reported that only 15% of the study participants were aware of their DR [26].

We found that participants with a longer DM duration and higher fasting blood glucose had better awareness that DM can affect the eyes. This finding is of no surprise, as both the duration of DM and blood glucose levels are known risk factors for DM-related complications [25, 27]. Furthermore, people with more severe DM and a longer duration of DM may have stronger initiatives and more opportunities to receive education regarding DM. Hypertension is another proven risk factor for DM and related complications [28], and people in our study with a history of hypertension also showed a better awareness that DM can affect the eyes. Even though dyslipidemia has been found to be a risk factor for DM [29], a history of hypercholesterolemia was not relevant to DR knowledge in our study. Patients with a better socio-economic background, including higher education level and income, had significantly better knowledge regarding DR compared to others. This is consistent with previous studies and could be due to better access to knowledge and a higher capability to understand [24, 30].

An annual dilated fundus examination is recommended for all patients with type 2 diabetes, but the reported awareness of the importance of routine check-ups is poor, even in developed countries [31]. In our study, only 29.5% of DM patients thought that they should have an annual eye examination, and the proportion was even lower for subjects who did not know that DM can affect the eyes (18.7% vs 36.1%). An awareness of regular examinations does not always lead to action. Only 10.2% of the study participants actually had yearly or more frequent eye examinations, which is much lower than that reported in United States (63%) [32], Switzerland (71%) [33] and Jordan (76%) [34]. No national DR screening program has been implemented in China. According to our study, 31.9% of the DM patients had never been told that a regular eye examination is necessary, and 80.9% of the DM patients had never had their eyes examined. The major barriers for eye examinations include a perception that their vision is not affected, followed by a lack of time and lack of company, suggesting that more educational programs and health support are needed to increase the service uptake among DM patients. Therefore, education about DR knowledge and the importance of regular eye exams should be enhanced in the CBPHS.

Physicians play an important role in imparting awareness and knowledge about DR. Our study found that most people knew about the necessity of regular eye examinations from a physician, and secondly, from an ophthalmologist. Studies have also shown that physicians constitute the most important source of information in the knowledge gap for DM patients [35, 36]. In our study, only 6% of the participants knew that DM had affected their eye by a fundus examination after pupil dilation, and this proportion was as low as 1% for people who did not know that DM can affect the eyes. Most people knew that their eyes had been affected only after they experienced discomfort in the eye (43.1%), which could represent that the disease has evolved to later stages. Early detection and intervention are of vital importance to prevent sight-threatening and irreversible complications of DR. Thus, community-based and hospital-based educational programs, including posters, pamphlets, and screening camps, could be helpful for enhancing patients’ awareness and knowledge to improve attitudes and practice. We believe that our study has highlighted the need for promoting knowledge regarding DR among DM patients, as well as shed light on potential barriers and interventions for policy-making in the future.

A limitation of this study concerns the representativeness of the study population, this study is based on the CBPHS and not strictly population-based. In addition, this study was cross-sectional in design, and further research is needed to investigate the short- and long-term health outcomes for DM patients with different levels of knowledge and practices toward DR.

In conclusion, with the existing chronic disease management system (free regular blood glucose tests and other types of DM management), the knowledge and practices regarding DR still haven’t been improved. Routine ophthalmic screening and management of DR in DM patients should be emphasized, efforts should be directed toward health care promotions, and educational programs should be implemented for better patient outcomes. A more integrated and effective chronic disease management system is needed and should be improved gradually.

Acknowledgments

We thank statistician Ling Jin, who provided the help for statistical analysis.

Data Availability

Relevant data that support the findings of this study are in the paper. The minimal dataset required to reproduce the results of the paper are not publicly available due to research participants did not consent to have their individual data publicly shared. The data are available on request from the Yueqing Hospital Ethical Review Board, please direct requests to the ethics committee coordinator Miss CHEN, qianyunchen@aliyun.com.

Funding Statement

This study was supported partly by National Natural Science Foundation of China (81400381) and Zhejiang Medical and Health Science and Technology Project (2018269795).

References

  • 1.Al-Lawati JA. Diabetes Mellitus: A Local and Global Public Health Emergency! Oman Med J. 2017;32(3):177–9. 10.5001/omj.2017.34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. 10.1016/j.diabres.2018.02.023 [DOI] [PubMed] [Google Scholar]
  • 3.Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–23. 10.1001/jama.2017.7596 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang FH, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009;116(3):461–7. 10.1016/j.ophtha.2008.10.003 [DOI] [PubMed] [Google Scholar]
  • 5.Liu DP, Molyneaux L, Chua E, Wang YZ, Wu CR, Jing H, et al. Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res Clin Pract. 2002;56(2):125–31. 10.1016/s0168-8227(01)00349-7 [DOI] [PubMed] [Google Scholar]
  • 6.Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114(6):723–30. 10.1016/s0002-9394(14)74051-6 [DOI] [PubMed] [Google Scholar]
  • 7.Wang WQ, Ip TP, Lam KS. Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong. Diabetes Res Clin Pract. 1998;39(3):185–91. 10.1016/s0168-8227(98)00002-3 [DOI] [PubMed] [Google Scholar]
  • 8.Wang D, Ding X, He M, Yan L, Kuang J, Geng Q, et al. Use of eye care services among diabetic patients in urban and rural China. Ophthalmology. 2010;117(9):1755–62. 10.1016/j.ophtha.2010.01.019 [DOI] [PubMed] [Google Scholar]
  • 9.Almalki NR, Almalki TM, Alswat K. Diabetics Retinopathy Knowledge and Awareness Assessment among the Type 2 Diabetics. Open Access Maced J Med Sci. 2018;6(3):574–7. 10.3889/oamjms.2018.121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283(7):889–96. 10.1001/jama.283.7.889 [DOI] [PubMed] [Google Scholar]
  • 11.Thompson AC, Thompson MO, Young DL, Lin RC, Sanislo SR, Moshfeghi DM, et al. Barriers to Follow-Up and Strategies to Improve Adherence to Appointments for Care of Chronic Eye Diseases. Invest Ophthalmol Vis Sci. 2015;56(8):4324–31. 10.1167/iovs.15-16444 [DOI] [PubMed] [Google Scholar]
  • 12.Duan F, Liu Y, Chen X, Congdon N, Zhang J, Chen Q, et al. Influencing factors on compliance of timely visits among patients with proliferative diabetic retinopathy in southern China: a qualitative study. BMJ Open. 2017;7(3):e013578 10.1136/bmjopen-2016-013578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lawrenson JG, Graham-Rowe E, Lorencatto F, Burr J, Bunce C, Francis JJ, et al. Interventions to increase attendance for diabetic retinopathy screening. Cochrane Database Syst Rev. 2018;1:CD012054 10.1002/14651858.CD012054.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yip W, Hsiao W. Harnessing the privatisation of China's fragmented health-care delivery. Lancet. 2014;384(9945):805–18. 10.1016/S0140-6736(14)61120-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wang Z, Shi J, Wu Z, Xie H, Yu Y, Li P, et al. Changes in chronic disease management among community health centers (CHCs) in China: Has health reform improved CHC ability? Int J Health Plann Manage. 2017;32(3):317–28. 10.1002/hpm.2433 [DOI] [PubMed] [Google Scholar]
  • 16.Hussain R, Rajesh B, Giridhar A, Gopalakrishnan M, Sadasivan S, James J, et al. Knowledge and awareness about diabetes mellitus and diabetic retinopathy in suburban population of a South Indian state and its practice among the patients with diabetes mellitus: A population-based study. Indian J Ophthalmol. 2016;64(4):272–6. 10.4103/0301-4738.182937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Xiong Yi L L-P, Chen Yan, Zhao Jie. Survey on the awareness of diabetic retinopathy among people with diabetes in the Songnan community of Shanghai. Int Eye Sci. 2015;15(7):1117–22. [Google Scholar]
  • 18.Livingston PM, Wood CA, McCarty CA, Harper CA, Keeffe JE, Taylor HR. Awareness of diabetic retinopathy among people who attended a diabetic retinopathy screening program. Med J Aust. 1998;169(2):117. [DOI] [PubMed] [Google Scholar]
  • 19.Dandona R, Dandona L, John RK, McCarty CA, Rao GN. Awareness of eye diseases in an urban population in southern India. Bull World Health Organ. 2001;79(2):96–102. [PMC free article] [PubMed] [Google Scholar]
  • 20.Merz CN, Buse JB, Tuncer D, Twillman GB. Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. J Am Coll Cardiol. 2002;40(10):1877–81. 10.1016/s0735-1097(02)02529-9 [DOI] [PubMed] [Google Scholar]
  • 21.Liu L, Chen L. Awareness of diabetic retinopathy is the key step for early prevention, diagnosis and treatment of this disease in China. Patient Educ Couns. 2014;94(2):284–5. 10.1016/j.pec.2013.10.026 [DOI] [PubMed] [Google Scholar]
  • 22.Sapkota R, Chen Z, Zheng D, Pardhan S. The profile of sight-threatening diabetic retinopathy in patients attending a specialist eye clinic in Hangzhou, China. BMJ Open Ophthalmol. 2019;4(1):e000236 10.1136/bmjophth-2018-000236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.International Diabetes Federation Guideline Development G. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1–52. 10.1016/j.diabres.2012.10.001 [DOI] [PubMed] [Google Scholar]
  • 24.Ullah F, Afridi AK, Rahim F, Ashfaq M, Khan S, Shabbier G, et al. Knowledge of Diabetic Complications in Patients with Diabetes Mellitus. J Ayub Med Coll Abbottabad. 2015;27(2):360–3. [PubMed] [Google Scholar]
  • 25.Pan CW, Wang S, Qian DJ, Xu C, Song E. Prevalence, Awareness, and Risk Factors of Diabetic Retinopathy among Adults with Known Type 2 Diabetes Mellitus in an Urban Community in China. Ophthalmic Epidemiol. 2017;24(3):188–94. 10.1080/09286586.2016.1264612 [DOI] [PubMed] [Google Scholar]
  • 26.Yang X, Deng Y, Gu H, Ren X, Lim A, Snellingen T, et al. Relationship of retinal vascular calibre and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study. Br J Ophthalmol. 2016;100(10):1359–65. 10.1136/bjophthalmol-2014-306078 [DOI] [PubMed] [Google Scholar]
  • 27.Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al. Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina. 2012;32(2):322–9. 10.1097/IAE.0b013e31821c4252 [DOI] [PubMed] [Google Scholar]
  • 28.Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008–2011. Invest Ophthalmol Vis Sci. 2013;54(10):6827–33. 10.1167/iovs.13-12654 [DOI] [PubMed] [Google Scholar]
  • 29.Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59. 10.1001/jama.2013.168118 [DOI] [PubMed] [Google Scholar]
  • 30.AlHargan MH, AlBaker KM, AlFadhel AA, AlGhamdi MA, AlMuammar SM, AlDawood HA. Awareness, knowledge, and practices related to diabetic retinopathy among diabetic patients in primary healthcare centers at Riyadh, Saudi Arabia. J Family Med Prim Care. 2019;8(2):373–7. 10.4103/jfmpc.jfmpc_422_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2011;129(4):435–44. 10.1001/archophthalmol.2010.319 [DOI] [PubMed] [Google Scholar]
  • 32.Eppley SE, Mansberger SL, Ramanathan S, Lowry EA. Characteristics Associated with Adherence to Annual Dilated Eye Examinations among US Patients with Diagnosed Diabetes. Ophthalmology. 2019. 10.1016/j.ophtha.2019.05.033 [DOI] [PubMed] [Google Scholar]
  • 33.Konstantinidis L, Carron T, de Ancos E, Chinet L, Hagon-Traub I, Zuercher E, et al. Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort. BMC Endocr Disord. 2017;17(1):56 10.1186/s12902-017-0206-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bakkar MM, Haddad MF, Gammoh YS. Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan. Diabetes Metab Syndr Obes. 2017;10:435–41. 10.2147/DMSO.S140841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ovenseri-Ogbomo GO, Abokyi S, Koffuor GA, Abokyi E. Knowledge of diabetes and its associated ocular manifestations by diabetic patients: A study at Korle-Bu Teaching Hospital, Ghana. Niger Med J. 2013;54(4):217–23. 10.4103/0300-1652.119602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Srinivasan NK, John D, Rebekah G, Kujur ES, Paul P, John SS. Diabetes and Diabetic Retinopathy: Knowledge, Attitude, Practice (KAP) among Diabetic Patients in A Tertiary Eye Care Centre. J Clin Diagn Res. 2017;11(7):NC01–NC7. 10.7860/JCDR/2017/27027.10174 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Wen-Jun Tu

16 Apr 2020

PONE-D-19-29504

Knowledge and attitudes regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

PLOS ONE

Dear Mr. Chen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by May 31 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Wen-Jun Tu

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This study was supported partly by National Natural Science Foundation of China (81400381) and Zhejiang Medical and Health Science and Technology Project (2018269795)."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The authors received no specific funding for this work."

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

I would like to congratulate the authors for their efforts in studying a topic that is so relevant. I would like to bring to their attention the following:

1. Sampling: The authors have mentioned that participants were randomly sampled. This has the potential to introduce bias, hence It would be beneficial to the readers if this was explained further.

2. Validation: Was the questionnaire validated? The questionnaire could be attached as a supplementary file.

3. Table 4: It is not clear what the authors are trying to depict in this table. The column “All” probably needs to be deleted.

4. One of the components of the knowledge score is “DM can cause blindness”. This should not be compared with “concern about vision loss” as both mean the same.

5. The same comment goes for “regular eye exams are necessary” which is a component of knowledge score, should not be compared with “told regular examinations should be done”

6. Strength of association: Although the authors comment on the significant association between knowledge score and various factors, there is however no comment on the strength of association. There appears to be only a week association between most of the factors except college education.

“concern about vision loss” and “told regular examinations should be done” also have a higher strength of association for obvious reasons as they are part of the knowledge score. These should not be compared.

Reviewer #2: Dear colleague. I enjoyed reading the manuscript. I have a few suggestions enclosed with the PDF as comments. I have a concern regarding use of the term "Knowledge and attitudes", when really, after reading the paper, i get a sense that knowledge, practices, risk factors for poor knowledge and lack of screening, and sources of information have been inquired. Also, I suggest adding an explanation about how variables were selected for the multiple linear regression.

Reviewer #3: The authors have used a questionnaire based approach to gather the information. They sought to find out the knowledge and attitudes of diabetic patients to the aspects of diabetic retinopathy. The authors have not scientifically adequately addressed the research question of attitudes. The study has not accounted for some confounding variables such as source of the information and access to information if formal or informal and if any person known to the patient or the person himself/herself already had retinopathy. The study does not add any scientifically sound useful information.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr. Vivek Gupta

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-19-29504_reviewer VG.pdf

PLoS One. 2020 Aug 21;15(8):e0234733. doi: 10.1371/journal.pone.0234733.r002

Author response to Decision Letter 0


12 May 2020

Dear Editors and Reviewers:

Thank you for your valuable suggestions and comments concerning our manuscript entitled “Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China”. Those comments are all extremely helpful for revising and improving our paper. We have carefully made necessary corrections accordingly, and highlighted in the paper.

Review Comments to the Author



Reviewer #1:

Dear authors,
I would like to congratulate the authors for their efforts in studying a topic that is so relevant. I would like to bring to their attention the following:

1. Sampling: The authors have mentioned that participants were randomly sampled. This has the potential to introduce bias, hence It would be beneficial to the readers if this was explained further.

Response: Thanks for your suggestion. We totally agree that we need to maximize the validity of inferences from what was observed in the study sample to what is happening in the population. The participants in our study were selected by simple random sampling method. We had edited in our manuscript.


2. Validation: Was the questionnaire validated? The questionnaire could be attached as a supplementary file.

Response: Thanks for asking this question. We actually did not validate that questionnaire since it has been used/validated in a previous published study from our institution (Ophthalmology.2010; 117:1755-62) with very few modifications.


3. Table 4: It is not clear what the authors are trying to depict in this table. The column “All” probably needs to be deleted.

Response: Thanks for your suggestion. We tried to display the responses of the participants to 7 different questions of DR knowledge. And we had deleted the column “All” in table 4 accordingly.


4. One of the components of the knowledge score is “DM can cause blindness”. This should not be compared with “concern about vision loss” as both mean the same.

Response: Thanks for your comments. We were trying to answering this similar question from two different approaches here, the score of “DM can cause blindness” was hoping to understand more from knowledge level, “concern about vision loss” was hoping to understand it from psychological level, so that we can see whether knowledge or psychological effects will interact on the same question or not.


5. The same comment goes for “regular eye exams are necessary” which is a component of knowledge score, should not be compared with “told regular examinations should be done”

Response: Similar like comments No.4, we were trying to answering the same question from different approaches. “regular eye exams are necessary” was hoping to understand it from knowledge level, “told regular examinations should be done” was hoping to find out whether this knowledge had been given by health care professionals, since even it had been told, but people may still say we didn’t feel it is necessary. We just tried to understand it in details.


6. Strength of association: Although the authors comment on the significant association between knowledge score and various factors, there is however no comment on the strength of association. There appears to be only a week association between most of the factors except college education.

Response: Thanks for your great suggestion. We had added it in the results section.


“concern about vision loss” and “told regular examinations should be done” also have a higher strength of association for obvious reasons as they are part of the knowledge score. These should not be compared.

Response: Please refer to our responses for comments No.4 and 5.



Reviewer #2:

Dear colleague. I enjoyed reading the manuscript. I have a few suggestions enclosed with the PDF as comments. I have a concern regarding use of the term "Knowledge and attitudes", when really, after reading the paper, i get a sense that knowledge, practices, risk factors for poor knowledge and lack of screening, and sources of information have been inquired. Also, I suggest adding an explanation about how variables were selected for the multiple linear regression.

Response: Thanks for your kind words and encouragement. We had edited our manuscript according to your suggestions. We had changed the word “attitudes” to “practice” in the title. And we had added an explanation about how variables were selected for the multiple linear regression. For most of comments you made in PDF, we have revised it directly in the manuscript with highlights.

I suggest that the authors avoid making a direct comparison with pre-CBPHS results of another region's population.

Response: Thanks for this valuable comments. We agree that a direct comparison may not be that appropriate, we have modified it accordingly.


Reviewer #3:

The authors have used a questionnaire based approach to gather the information. They sought to find out the knowledge and attitudes of diabetic patients to the aspects of diabetic retinopathy. The authors have not scientifically adequately addressed the research question of attitudes. The study has not accounted for some confounding variables such as source of the information and access to information if formal or informal and if any person known to the patient or the person himself/herself already had retinopathy. The study does not add any scientifically sound useful information.

Response: Thanks for taking the time and efforts to review our manuscript, we appreciate your constructive comments and agree that we need to continue to improve the quality of this manuscript. Here are our responses to the comments:

We agree that the term “attitude” was not appropriate to use, it was the “knowledge” of those participants being studied mostly in the manuscript. Therefore the term of “practice” is now being used to replace “attitude”.

Authors couldn’t agree anymore on the comments of potential confounding variables, those were indeed important factors we needed to address in this type of the observational study. The participants in our study were selected by simple random sampling method. Questionnaires were administered by a trained community physician, to help the participants fully understand the questions being asked. We have put some of potential confounding variables as the limitations in our manuscript (such as the source of the DM/DR information, the accessibility of the DM/DR information).

A few studies have been done to investigate the knowledge of DM/DR in general population in China, including a team from our institution, however, none was implemented after the established of chronic disease management system in 2009. The system was intended to manage patients and prevent complication, the aim of our paper was to access the current system’s influence on DM/DR knowledge fronts, and we hope our results can provide some new evidence on how to improve that chronic disease system. And we believe the cause of problem of DM/DR knowledge is quite universal.

Again, we appreciate all of your insightful comments. Thank you for taking the time to help us improve the paper, really appreciated!

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Wen-Jun Tu

2 Jun 2020

Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

PONE-D-19-29504R1

Dear Dr. Chen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wen-Jun Tu

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank You for addressing the concerns with the initial submission, that were raised in the first review.

Reviewer #3: The manuscript is better now. The authors have revised the paper keeping in view the reviewer comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Dr Vivek Gupta

Reviewer #3: No

Acceptance letter

Wen-Jun Tu

8 Jun 2020

PONE-D-19-29504R1

Knowledge and practices regarding diabetic retinopathy among diabetic patients registered in a chronic disease management system in eastern China

Dear Dr. Chen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wen-Jun Tu

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PONE-D-19-29504_reviewer VG.pdf

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Relevant data that support the findings of this study are in the paper. The minimal dataset required to reproduce the results of the paper are not publicly available due to research participants did not consent to have their individual data publicly shared. The data are available on request from the Yueqing Hospital Ethical Review Board, please direct requests to the ethics committee coordinator Miss CHEN, qianyunchen@aliyun.com.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES